Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1158/0008-5472.CAN-19-0560 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
RETRACTION: DPM2 Serve as Novel Oncogene and Prognostic Marker Transactivated by ESR1 in Breast Cancer.
Environ Toxicol
November 2024
J. Lu, Y. Feng, Y.
View Article and Find Full Text PDFRetraction Note: The autocrine glycosylated-GREM1 interacts with TGFB1 to suppress TGFβ/BMP/SMAD-mediated EMT partially by inhibiting MYL9 transactivation in urinary carcinoma.
Cell Oncol (Dordr)
December 2024
Institute of Precision Medicine, College of Medicine, National Sun Yat-Sen University, Kaohsiung, 80424, Taiwan.
Retraction Note: Endothelin-1 induces the transactivation of vascular endothelial growth factor receptor-3 and modulates cell migration and vasculogenic mimicry in melanoma cells.
J Mol Med (Berl)
November 2024
Molecular Pathology Laboratory "A", Regina Elena National Cancer Institute, Rome, Italy.
DPM2 serve as novel oncogene and prognostic marker transactivated by ESR1 in breast cancer.
Environ Toxicol
March 2024
Shanghai Putuo Central School of Clinical Medicine, Anhui Medical University, Shanghai, China.
Breast cancer (BRCA) is the most common malignancies worldwide with increasing rate. Dolichol phosphate mannose synthase (DPMS) is a critical mannosyltransferase involved in the posttranslational modification of proteins. At present, there is limited knowledge regarding the function of DPMS in breast cancer.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!